Atlas Trials

Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient

Clinical trial NCT03193073 · SUSPENDED

Trial details

NCT number
NCT03193073
Sponsor
Omnia Mohammed Hashem
Status
SUSPENDED
Phase
Not Applicable
Study type
INTERVENTIONAL
Anemia of Chronic Kidney DiseaseEndothelial DysfunctionLeft Ventricular HypertrophyFibroblast Growth Factor 23
Start date
2018-09-01
Primary completion
2020-09-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.